If you are a member of the network, please log in to access Network content and tools. If you do not have a username, contact your site principal investigator or site coordinator and request that they complete a membership request for you. If you have forgotten your password, you may CLICK HERE.


You are here

The Autism Impact Measure (AIM): Initial Development of a New Tool for Treatment Outcome Measurement

TitleThe Autism Impact Measure (AIM): Initial Development of a New Tool for Treatment Outcome Measurement
Publication TypeJournal Article
Year of Publication2013
AuthorsKanne, SM, Mazurek, MO, Sikora, DM, Bellando, J, Branum-Martin, L, Handen, BL, Katz, TF, Freedman, B, Powell, MPaige, Warren, ZE
JournalJournal of Autism and Developmental Disorders

Lead Author
Stephen M. Kanne

Study Aims and Objectives
To describe the development and properties of a parent report measure aimed at measuring Autism Spectrum Disorder treatment outcomes.

Methods- Sample, Procedure, Study Measures, Analysis
The Autism Impact Measure (AIM) is a parent report measure designed to assess the impact treatment has on individuals with ASD. By gathering data from 440 children and adolescents with well characterized ASD, researchers were able to define several categories used to measure symptom severity, impact, occurrence rates, and progress.

Results- Main Findings
Meaningful categories of symptom measurement were created and validated using various analytical approaches. This study found that the measure provides reliable results that are easy to complete and score. The AIM uses a clinically meaningful approach to ensure that families and providers are able to gather data and interpret any progress made.

Conclusion- Summary Statement
This AIM application is a valid and reliable tool that can be used to track any progress made by individuals with ASD in terms of treatment and symptom changes. Tracking short term and intermediate changes is extremely important when determining treatment pathways. By allowing families and individuals to track symptom frequency and severity in one easily accessible place, providers can create tailored treatment plans to ensure continual progression.

PubMed ID23748386